Adam Schayowitz
EVP, Head of R&D
1 filing on record here, covering ZYME. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-10-09
| Exercise | ZYME | Zymeworks Inc. | |
| Sell | ZYME | Zymeworks Inc. | $357,557 |
| Exercise | ZYME | Zymeworks Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.